drugset / Trial / NCT00732251
Allopurinol Maintenance Study for Bipolar Disorder
Phase 4
Terminated
15 enrolled
Cedars-Sinai Medical Center
West Coast College of Biological Psychiatry Inc · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to investigate the efficacy of allopurinol as an augmentation agent for the prevention of mania in bipolar disorder patients with currently stable mood.
Timeline
- Start
- 2008-08
- Primary completion
- 2012-01
- Completion
- 2012-01
Outcome
Outcome not reported
Stopped: “The outpatient area of the department of psychiatry at CSMC closed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allopurinol | Small molecule | 300 mg | — |
| Subject | Allopurinol | Small molecule | 600 mg | — |